Volume 2 Number 4
Editorial
72
FDA panel, 7 and 8 December 2006 - The impact on our practice and researchEuroInterv.2007;2:405-407
74
Drug eluting stents in left main stem stenosis: patients will pay the priceEuroInterv.2007;2:410-412
20 years of stenting
EAPCI column
77
The latest news from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)EuroInterv.2007;2:423-425
Clinical research
78
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trialChevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D, for the Nobori 1 Clinical Investigators
EuroInterv.2007;2:426-434
79
Revisiting the incidence and temporal distribution of cardiac and sudden death in patients undergoing elective intervention for unprotected left main coronary artery stenosis in the drug eluting stent era A pooled analysis on 340 patients treated at three European referral centres
Valgimigli M, Chieffo A, Lefèvre T, Colombo A, Morice M-C, Serruys PW, on behalf of the Executive Committee of the Syntax Study
EuroInterv.2007;2:435-443
80
Endovascular therapy of chronic mesenteric ischaemiaZeller T, Rastan A, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K, Sixt S, Müller C, Rothenpieler U, Neumann F-J
EuroInterv.2007;2:444-451
81
Predicting coronary artery bypass graft surgery in acute coronary syndromesBrieger D, Elsik M, Gore J, Knobel E, Nussbacher A, Piegas L, Allegrone J, Anderson F, Avezum A, on behalf of the Global Registry of Acute Coronary Events investigators (GRACE)
EuroInterv.2007;2:452-458
82
The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatationNienaber C, Hamm C, Weber F, Zeymer U, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Richardt G, Senges J, for the German Cypher Stent Registry
EuroInterv.2007;2:459-466
83
Advantage of sirolimus-eluting stents compared to intracoronary radiation therapy 30 months after treatment of in-stent restenosisIofina E, Gorchtein V, Radke P, Schubert D, Franke A, Langenberg R, Hanrath P, vom Dahl J, Hoffmann R
EuroInterv.2007;2:467-473
84
Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registryVarani E, Saia F, Balducelli M, Guastaroba P, Marrozzini C, Tarantino F, Passerini F, Sangiorgio P, Percoco G, Grilli R, Marzocchi A, Maresta A, for the REAL Investigators
EuroInterv.2007;2:474-480
85
The impact of age and Killip class on outcomes of primary percutaneous coronary intervention. Insight from the PRAGUE-1 and -2 trials and registry
EuroInterv.2007;2:481-486
86
Comparison of the in vitro performance of 6 and 7 French aspiration cathetersHara H, Nakamura M, Komatsu H, Ikeda N, Shinji H, Makino K, Itaya H, Yamamoto M, Itou N, Tsunoda T, Sugi K
EuroInterv.2007;2:487-492
87
A simple risk score for prediction of mortality in patients undergoing percutaneous coronary intervention (PCI) for non-ST segment elevation acute coronary syndromes (NSTEACS)EuroInterv.2007;2:493-499
Special report
88
True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar XL and the TandemHeart de Jaegere P, van Dijk L, Laborde J-C, Sianos G, Orellana Ramos FJ, Ligthart J, Kappetein AP, van der Ent M, Serruys PW
EuroInterv.2007;2:500-505
Technical report
Expert review
92
Bifurcated stents: giving to Caesar what is Caesar'sAbizaid A, de Ribamar Costa Junior J, Alfaro V, Feres F, Staico R, Mattos L, Maldonado G, Eduardo Sousa J
EuroInterv.2007;2:518-525
93
The evolving role of coronary angiography and fluoroscopy in cardiac diagnosis and intervention EuroInterv.2007;2:526-532
Image in cardiology
94
Left ventricular angiogram in a patient with noncompaction cardiomyopathy EuroInterv.2007;2:533-534
Volume 2 Number 4 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Boston Scientific
- Cordis, a Johnson & Johnson company
- Hexacath
- Medtronic
- Terumo



